MiMARK

Barcelona, Spain · Founded 2021 · Privately Held (backing)

Operator of a biotech platform designed to reshape gynecological diagnostics through fluid-based testing. MiMARK is based in Barcelona, Spain and was founded in 2021. Its last reported valuation was $32.9 million in Oct 2025. It has raised $8.8 million.

Last reported valuation
$32.9M
Oct 2026
Priced at
—
Total raised
$8.8M
Last round
—

Who backs MiMARK?

14 investors
InvestorType
European Innovation CouncilVenture capital
Inveready Asset ManagementVenture capital
Clave (Pamplona)Venture capital
PharmStarsOther
CDTI InnvierteOther
CIMTI—
Canterbury Scientific—
Catalonia.Health—
Chemostart—
EIT Health—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

MiMARK investors

14 investors are on record for MiMARK, including European Innovation Council, Inveready Asset Management, Clave (Pamplona) and PharmStars.

Free account
More of MiMARK with a free account
  • ·The complete investor list: 14 names
  • ·Watch MiMARK: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like MiMARK. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View